XTL Biopharmaceuticals Ltd (XTLB) — Cash Flow Quality Index
XTL Biopharmaceuticals Ltd (XTLB) has a Cash Flow Quality Index of -0.15x as of September 2017. Operating cash flow of ILA-240.00K is below net income of ILA1.59 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore XTL Biopharmaceuticals Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
XTL Biopharmaceuticals Ltd Cash Flow Quality Index (2018–2021)
Historical Cash Flow Quality Index for XTL Biopharmaceuticals Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore XTLB long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Quality Index for XTL Biopharmaceuticals Ltd (2018–2021)
Year-by-year earnings quality comparison for XTL Biopharmaceuticals Ltd. For live market cap and the full company financial profile, see XTL Biopharmaceuticals Ltd market capitalisation.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.41x | ILA-1.05 Million | ILA435.00K | ▼ -972.8% |
| 2018 | -0.22x | ILA-816.00K | ILA3.63 Million | — |